Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Ponderano – page 19

276 clinical trials in Ponderano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Ponderano at a glance
276
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

276 trials in Ponderano

Open in trial search

Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:PTC Therapeutics Inc.

Study on Patidegib Gel for Reducing Basal Cell Carcinomas in Adults with Gorlin Syndrome

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Sol-Gel Technologies Ltd.

Study on Povetacicept for Patients with Autoimmune Cytopenias (wAIHA, CAD, ITP)

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Povetacicept
  • Sponsor:Alpine Immune Sciences Inc.

Study on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Incyte Corp.

Study Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Association International Extranodal Lymphoma Study Group (IELSG)

Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Long-term Study on the Safety and Efficacy of Efgartigimod in Adults with Primary Immune Thrombocytopenia

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Registered drug
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.

Study on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Genmab A/S

Study on Trastuzumab Deruxtecan, Trastuzumab, and Pertuzumab for Patients with HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Pertuzumab
  • Sponsor:Medica Scientia Innovation Research S.L.

Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Acerta Pharma B.V.

Other cities in Italy

The busiest research cities in the country

All 230 cities in Italy

Clinical research in Ponderano

What the registry says about research in the country

01 Oncology Research

Clinical trials focusing on innovative treatments for various cancer types, including colorectal cancer, lymphoma, and endometrial cancer. Studies evaluate novel therapeutic combinations and personalized treatment approaches.

  • Advanced Pancreatic Cancer Treatment
  • Lymphoma Therapy Optimization
  • Targeted Colorectal Cancer Interventions

Research emphasizes improving survival rates and treatment efficacy through immunotherapy and targeted molecular approaches.

02 Neurological Disorders

Investigations into treatments for Multiple Sclerosis and Alzheimer's Disease, with particular focus on managing associated symptoms and disease progression.

  • MS Long-term Treatment Evaluation
  • Alzheimer's-related Psychosis Management
  • Innovative Therapeutic Approaches

Studies aim to enhance quality of life and develop more effective treatment strategies.

03 Infectious Diseases

Research on treating gram-negative bacterial infections in vulnerable populations, including studies of new antibiotics and treatment protocols.

  • Neonatal Infection Treatment
  • Hospital-acquired Pneumonia
  • Complex Bacterial Infections

Focus on developing safer and more effective treatments for severe infections.

04 Addiction Medicine

Studies examining treatments for alcohol dependence, with emphasis on reducing consumption and maintaining abstinence in high-risk patients.

  • Alcohol Consumption Reduction
  • Maintenance Therapy
  • Risk Level Management

Research aims to improve treatment outcomes for alcohol-dependent individuals.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.